wanghaibo
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative HR Positive HER2 Negative Advanced Breast Cancer | Phase 2 | 2025-06-25 |